176 related articles for article (PubMed ID: 11940107)
41. Treatment of type 1 diabetes with insulin lispro during Ramadan.
Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
[TBL] [Abstract][Full Text] [Related]
42. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
[TBL] [Abstract][Full Text] [Related]
43. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
[TBL] [Abstract][Full Text] [Related]
44. Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia.
Rönnemaa T; Viikari J
Diabet Med; 1998 Jul; 15(7):601-7. PubMed ID: 9686701
[TBL] [Abstract][Full Text] [Related]
45. Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin.
Ferguson SC; Strachan MW; Janes JM; Frier BM
Diabetes Metab Res Rev; 2001; 17(4):285-91. PubMed ID: 11544612
[TBL] [Abstract][Full Text] [Related]
46. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
47. Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
Fabricius TW; Verhulst CEM; Kristensen PL; Holst JJ; Tack CJ; McCrimmon RJ; Heller SR; Evans ML; de Galan BE; Pedersen-Bjergaard U;
Acta Diabetol; 2024 May; 61(5):623-633. PubMed ID: 38376580
[TBL] [Abstract][Full Text] [Related]
48. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
[TBL] [Abstract][Full Text] [Related]
49. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
Choudhary P; Davies C; Emery CJ; Heller SR
Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
[TBL] [Abstract][Full Text] [Related]
50. Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.
Altuntas Y; Ozen B; Ozturk B; Sengul A; Ucak S; Ersoy O; Karul S
Diabetes Obes Metab; 2003 Nov; 5(6):371-8. PubMed ID: 14617222
[TBL] [Abstract][Full Text] [Related]
51. Basal insulin replacement and use of rapid-acting insulin analogues in patients with type 1 diabetes.
Zinman B
Endocr Pract; 2000; 6(1):88-92. PubMed ID: 11419927
[TBL] [Abstract][Full Text] [Related]
52. Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.
Dagogo-Jack S; Askari H; Morrill B; Lehner LL; Kim B; Sha X
Diabetes Obes Metab; 2000 Dec; 2(6):373-83. PubMed ID: 11225967
[TBL] [Abstract][Full Text] [Related]
53. Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group.
Akram J; De Verga V
Diabet Med; 1999 Oct; 16(10):861-6. PubMed ID: 10547214
[TBL] [Abstract][Full Text] [Related]
54. Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
Janssen MM; Snoek FJ; Masurel N; Hoogma RP; Devillé WL; Popp-Snijders C; Heine RJ
Diabetes Care; 2000 May; 23(5):629-33. PubMed ID: 10834421
[TBL] [Abstract][Full Text] [Related]
55. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes.
Davis M; Mellman M; Friedman S; Chang CJ; Shamoon H
Am J Med; 1994 Dec; 97(6):535-42. PubMed ID: 7985713
[TBL] [Abstract][Full Text] [Related]
56. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
[TBL] [Abstract][Full Text] [Related]
57. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Heise T; Nosek L; Rønn BB; Endahl L; Heinemann L; Kapitza C; Draeger E
Diabetes; 2004 Jun; 53(6):1614-20. PubMed ID: 15161770
[TBL] [Abstract][Full Text] [Related]
58. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
59. Long-term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus.
Kuzi S; Mazaki-Tovi M; Hershkovitz S; Yas E; Hess RS
Vet Med Sci; 2023 Mar; 9(2):704-711. PubMed ID: 36795089
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.
Hermansen K; Madsbad S; Perrild H; Kristensen A; Axelsen M
Diabetes Care; 2001 Feb; 24(2):296-301. PubMed ID: 11213882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
